Kenya Is Set To Start Manufacturing Of Covid-19 Vaccine From 2022

0 0
Read Time:1 Minute, 26 Second

Photo Courtesy

Kenya is set to begin manufacturing locally made Covid-19 vaccines beginning the next year 2022 in collaboration with an unknown pharmaceutical firm in a move aimed at navigating hitches that have slowed down the vaccination process.

According to the Health Cabinet Secretary Mutahi Kagwe, The government is in the process of building up a filling plant for Covid-19 vaccines.

He also said that the fill and finish facility will help the third party to put the vaccines from the main manufacturers into the syringes before they are distributed.

“To improve our vaccine supply security, the government has embarked on the local manufacture of Covid-19 vaccines starting with the establishment of a fill-and finish facility through strategic partnerships and technological transfer,” Mr Kagwe said in the National Covid-19 Vaccine Deployment Plan, 2021.

A number of manufacturers use third parties to fill and finish their vaccines. Rwanda, South Africa and Senegal have also started talks with investors to facilitate the production of Covid-19 vaccines in their countries.

“We aim to start local production during the first quarter of 2022 and have a fully-fledged human vaccine manufacturing capability by 2024,” Cs said.

He also said that the local production will also help the country to help the country in getting a sufficient number of vaccines required in the country.

The government is planning to vaccinate over 10 million adults by December 2021 and 26 million adults by June 2021.

Kenya has been receiving vaccine donations from different countries like India, United States and the UK.

 

The post Kenya Is Set To Start Manufacturing Of Covid-19 Vaccine From 2022 appeared first on Jalango TV – Kenya No.1 Online TV.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply